- Home
- LYEL vs CIA Comparison
LYEL vs CIA Comparison
Compare LYEL & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- CIA
- Stock Information
- Founded
- LYEL 2018
- CIA 1969
- Country
- LYEL United States
- CIA United States
- Employees
- LYEL N/A
- CIA N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- LYEL Health Care
- CIA Finance
- Exchange
- LYEL Nasdaq
- CIA Nasdaq
- Market Cap
- LYEL 253.2M
- CIA 261.8M
- IPO Year
- LYEL 2021
- CIA N/A
- Fundamental
- Price
- LYEL $16.85
- CIA $5.56
- Analyst Decision
- LYEL Hold
- CIA
- Analyst Count
- LYEL 3
- CIA 0
- Target Price
- LYEL $16.67
- CIA N/A
- AVG Volume (30 Days)
- LYEL 67.5K
- CIA 147.0K
- Earning Date
- LYEL 11-06-2025
- CIA 11-06-2025
- Dividend Yield
- LYEL N/A
- CIA N/A
- EPS Growth
- LYEL N/A
- CIA N/A
- EPS
- LYEL N/A
- CIA 0.22
- Revenue
- LYEL $60,000.00
- CIA $245,943,000.00
- Revenue This Year
- LYEL N/A
- CIA $4.22
- Revenue Next Year
- LYEL N/A
- CIA $4.46
- P/E Ratio
- LYEL N/A
- CIA $25.28
- Revenue Growth
- LYEL 11.11
- CIA N/A
- 52 Week Low
- LYEL $7.65
- CIA $2.90
- 52 Week High
- LYEL $30.00
- CIA $5.99
- Technical
- Relative Strength Index (RSI)
- LYEL 60.29
- CIA 54.50
- Support Level
- LYEL $17.17
- CIA $5.20
- Resistance Level
- LYEL $19.44
- CIA $5.43
- Average True Range (ATR)
- LYEL 1.24
- CIA 0.22
- MACD
- LYEL 0.11
- CIA -0.03
- Stochastic Oscillator
- LYEL 62.23
- CIA 52.44
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.